Shenzhen Neptunus Interlong Bio-Technique Company Limited



Quote for Shenzhen Neptunus Interlong Bio-Technique Company Limited

Last Trade:
-
Change:
--
Symbol/Code:
08329
Status:
-
Type:
H Share
P/E:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume:
-
Amount:
-
Day's Range:
-
52 week Range:
-
Update:-
Quote Delayed 15 Min.
Currency in HKD Time=UTC+808329 quote

Summary for Shenzhen Neptunus Interlong Bio-Technique Company Limited

Shenzhen Neptunus Interlong Bio-Technique Company Limited is engaged in the research and development (R&D) business and sale of vaccines for infectious diseases in the People's Republic of China. The Company operates in two segments: manufacturing and selling of medicine products, and provision of R&D services of biological technology. The medical products segment derives its revenue from manufacture and sale of medical products. The R&D services segment derives its revenue from the provision of R&D services income. On December 14, 2010, the Company acquired 80% of Neptunus Fuyao and its subsidiaries (Neptunus Fuyao Group). As of December 31, 2010, the Company's subsidiaries included Ascendent Bio-Technology Company Limited, Fuzhou Neptunus Fuyao Pharmaceutical Company Limited and Taizhou Neptunus Bio-technique Company Limited.